During the past decade, Northwest Indiana Center for Clinical Research conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 34 clinical trials were completed, i.e. on average, 136% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 16 clinical trials were completed. i.e. 177.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Indiana Center for Clinical Research" #1 sponsor was "Pfizer" with 15 trials, followed by "Purdue Pharma LP" with 5 trials sponsored, "Kowa Research Institute, Inc." with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Cephalon" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Indiana Center for Clinical Research" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Shionogi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Indiana Center for Clinical Research" are "Obesity" (5 trials), "Osteoarthritis" (5 trials), "Diabetes Mellitus, Type 2" (4 trials), "Arthritis" (3 trials) and "Major Depressive Disorder" (3 trials). Many other conditions were trialed in "Northwest Indiana Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Northwest Indiana Center for Clinical Research" are "Drug" (35 trials), "Biological" (14 trials), "Other" (6 trials), "Behavioral" (2 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "K-877" (3 trials), "tanezumab" (3 trials), "Ancillary therapy" (2 trials) and "Fenofibrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Indiana Center for Clinical Research" are 48 trials for "All" genders.

Currently, there are NaN active trials in "Northwest Indiana Center for Clinical Research". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Northwest Indiana Center for Clinical Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Indiana Center for Clinical Research, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".